FDA CLEARED
Lung Acoustic Biomarkers for Better Health
As Featured In
![MedTech-Dive-logo](https://stradoslabs.com/wp-content/uploads/2024/02/fierce-biotech-logo.webp)
![MedTech-Dive-logo](https://stradoslabs.com/wp-content/uploads/2024/02/MedTech-Dive-logo.webp)
![MedTech-Dive-logo](https://stradoslabs.com/wp-content/uploads/2024/02/BioWorld-logo.webp)
![MedTech-Dive-logo](https://stradoslabs.com/wp-content/uploads/2024/02/MedCity-News-logo.webp)
![MedTech-Dive-logo](https://stradoslabs.com/wp-content/uploads/2024/02/Deep-Pharma-Intelligence-logo.webp)
![MedTech-Dive-logo](https://stradoslabs.com/wp-content/uploads/2024/02/TMF-logo.webp)
Measure What Matters to Patients
Patient self-reporting of respiratory symptoms like coughing and wheezing, while important, is subjective and doesn’t tell the whole story. Strados Labs is focused on making respiratory symptoms available at clinicians’ fingertips, offering objective insight into how patients respond to treatment plans, earlier warnings of exacerbations and more.
![](https://stradoslabs.com/wp-content/uploads/2024/07/healthcare-image.png)
Healthcare Settings
Manage lung health from hospital to home with real-time monitoring of symptoms
![](https://stradoslabs.com/wp-content/uploads/2024/07/lifescience-image-e1721842327891.jpg)
Life Sciences
Gain greater insight into treatment response in drug development and clinical trials
How It Works
An end-to-end solution for remote monitoring of lung health
![](https://stradoslabs.com/wp-content/uploads/2024/06/wave-device.png)
RESP® Biosensor
Patient adheres wearable device to their chest with an adhesive and device starts recording lung sounds
![](https://stradoslabs.com/wp-content/uploads/2024/06/mobile-and-wave.png)
Strados™ Mobile App
Lung sound data collected by the
RESP Biosensor is transferred to a companion patient mobile device via Bluetooth
![](https://stradoslabs.com/wp-content/uploads/2024/06/wave-laptop.png)
Strados™ Cloud
Cloud securely stores data and is available for reporting by Strados Labs’ team of trained annotators supported by machine learning algorithms
600k+
Validated Coughs Captured
19m+
Breaths Captured
4
35
2
1
The Award-Winning Technology Revolutionizing Lung Health
![](https://stradoslabs.com/wp-content/uploads/2024/04/privacy-and-security-icon.png)
Privacy & Security
![](https://stradoslabs.com/wp-content/uploads/2024/04/patient-friendly-icon.png)
Designed for Daily Life
![](https://stradoslabs.com/wp-content/uploads/2024/06/globe-cursor-icon.png)
Global Experience
![](https://stradoslabs.com/wp-content/uploads/2024/06/lung-icon.png)
Beyond Cough
Extended capabilities beyond cough frequency include intensity, bouts, lung sounds and vitals* for a fuller understanding of patient health.
![Data icon small](https://stradoslabs.com/wp-content/uploads/2024/06/data-icon.png)
Clinically Validated Accuracy
*Measurement not FDA-cleared
News & Resources
![Strados Labs featured at the Respiratory Innovation Summit at ATS 2024](https://stradoslabs.com/wp-content/uploads/2024/04/2024-ris-poster.webp)
Strados Labs featured at the Respiratory Innovation Summit at ATS 2024
Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at ATS 2024 in San Diego, CA where Strados was also an exhibitor (Booth 1131). RIS took place from May 17-18. Hosted by the American Thoracic Society, the Respiratory Innovation Summit...
![Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant](https://stradoslabs.com/wp-content/uploads/2024/03/FDA-Department-of-health-and-human-services.webp)
Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant
In November 2023, Merck's chronic cough drug, gefapixant, faced a decisive setback from the FDA Advisory Committee. The concerns highlighted insufficient evidence for the drug providing a clinically meaningful benefit to adults with refractory chronic cough (RCC) or...
![Beyond Cough Count: Why It’s Time to Go Deeper in Cough Trials](https://stradoslabs.com/wp-content/uploads/2024/02/chest-pain-caugh-image.webp)
Beyond Cough Count: Why It’s Time to Go Deeper in Cough Trials
24-hour cough frequency has traditionally been recognized as the ‘gold standard’ primary endpoint for indications such as refractory chronic cough, chronic bronchitis, and IPF-related cough. While frequency is undoubtedly a valuable metric to measure for cough, there...